TARGETED AMATOXIN CONJUGATE FOR THE TREATMENT OF SOLID TUMORS
Assignee
Heidelberg Pharma Research GmbH
Inventors
Christoph Müller, Werner Simon, Christian Lutz, Susanne Werner-Simon, Torsten Hechler, Michael Kulke, Andreas Pahl
Abstract
An amatoxin-linker construct contains an amatoxin according to formula (I) wherein R1 and R2 are each —OH, R3 is NH2, or a linker which carries a reactive group Y for linking said amatoxin to a target-binding moiety, R4 is H or a linker which carries a reactive group Y for linking said amatoxin to a target-binding moiety, R5 is absent or ═O, and wherein R3 and R4 cannot be the same. The amatoxin-linker construct is used in the manufacture of a binding moiety-toxin conjugate for the treatment of a solid tumor, and a respective binding moiety-toxin conjugate can be used for the treatment of a solid tumor.
CPC Classifications
Filing Date
2025-10-06
Application No.
19350762